PDE IV-IN-1

CAS No. 225100-12-9

PDE IV-IN-1( —— )

Catalog No. M32762 CAS No. 225100-12-9

PDE IV-IN-1 is a potent phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory activity for the treatment of asthma, chronic obstructive pulmonary disease and other inflammatory diseases, and is a potential compound for the study of depression.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 571 In Stock
5MG 506 In Stock
10MG 677 In Stock
25MG 1017 In Stock
50MG 1330 In Stock
100MG 1795 In Stock
200MG 2409 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PDE IV-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    PDE IV-IN-1 is a potent phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory activity for the treatment of asthma, chronic obstructive pulmonary disease and other inflammatory diseases, and is a potential compound for the study of depression.
  • Description
    PDE IV-IN-1 is an inhibitor of phosphodiesterase IV, used for the research of asthma, COPD or other inflammatory diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    225100-12-9
  • Formula Weight
    386.88
  • Molecular Formula
    C20H23ClN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(N1C=2C(N=C1C)=C(C)N=C(Cl)N2)C3=CC(OC4CCCC4)=C(OC)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof. US 6919455 B2
molnova catalog
related products
  • ICI 63197

    ICI 63197 is a PDE4 inhibitor.

  • PQ-10

    PQ-10 is a PDE-10 inhibitor. PQ-10 induces brain glucose metabolism patterns, which may be a potential translational biomarker.

  • UK-369003

    UK-369003 (Gisadenafil besylate) is a novel, potent, selective, orally bioavailable PDE5 inhibitor with IC50 of 1.23 nM.